Source: The Good Flour Co.
  • The Good Flour Corp. (GFCO) announced a non-brokered private placement to raise gross proceeds of up to $2,000,000
  • The offering consists of units issued at $0.35 per unit
  • Each unit consists of one Class A common share and one transferable warrant
  • Each warrant entitles the holder to purchase an additional share for a period of three years from the date of issuance at an exercise price of $0.40 per share
  • The Good Flour Corp. is a corporation committed to investing in companies that are dedicated to providing the best in gluten-free and plant-based food products
  • The Good Flour Corp. (GFCO) opened trading at $0.38 per share

The Good Flour Corp. (GFCO) announced a non-brokered private placement to raise gross proceeds of up to $2,000,000.

The offering consists of units issued at $0.35 per unit. Each unit consists of one Class A common share and one transferable warrant. Each warrant entitles the holder to purchase an additional share for a period of three years from the date of issuance at an exercise price of $0.40 per share.

Net proceeds will be used for general corporate, investor relations and working capital purposes.

GFCO may pay finder’s fees in connection with the offering.

The Good Flour Corp. is committed to investing in companies that are dedicated to providing the best in gluten-free and plant-based food products.

It currently provides flours and mixes that are designed to bring flavour, texture, versatility and ease to your gluten-free kitchen.

The Good Flour Corp. (GFCO) opened trading at $0.38 per share.


More From The Market Online

“Paw Patrol” owners see a 52-week share price high

Spin Master (TSX:TOY) reported 8.9 per cent revenue growth to US$436.4 million and returned to profitability.

Uber Eats expands grocery delivery network with new U.S. regional retail partners

Uber (NYSE:UBER) Eats added Busch’s Fresh Food Market, Hays, and Lowe’s Market to its grocery delivery marketplace across the U.S.

Cybersecurity stocks worth watching as digital risks continue to evolve

Cybersecurity threats continue to evolve, while recent disruptions highlighted the importance of resilient digital infrastructure.

A small-cap contender looking to challenge the weight-loss drug giants

Structure Therapeutics (NASDAQ:GPCR) is developing an oral weight-loss pill that could offer an alternative to popular injectable treatments.